Last updated on August 2009

Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis

Brief description of study

The purpose of this study is to establish whether RA patients with moderate to severe disease activity with unsustainable response to infliximab 3 mg/kg every 8 weeks have better efficacy with adalimumab 40 mg s.c. eow compared to infliximab 3 mg/kg i.v. every 6 weeks.

Clinical Study Identifier: NCT00216177

Find a site near you

Start Over


Copenhagen, Denmark
  Connect »

Glostrup Hospital

Copenhagen, Denmark
  Connect »

Hvidovre Hospital

Copenhagen, Denmark
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.